Skip to content

Drug interactions

Everolimus + Telotristat etiprate

Severity: Moderate

Everolimus and Telotristat etiprate: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Telotristat may reduce everolimus exposure through CYP3A4 induction, risking loss of antitumour efficacy or immunosuppression, which is a concern in neuroendocrine tumour treatment.

What this interaction means in plain words

Everolimus and Telotristat etiprate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Everolimus belongs to Oncology; Telotristat etiprate belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

CYP3A4 induction increases everolimus metabolism.

What to do

Monitor tumour response, or everolimus trough levels where used for transplant, and adjust the dose accordingly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Everolimus and Telotristat etiprate, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Everolimus with Telotristat etiprate?

MediHelp rates the interaction as moderate. Everolimus and Telotristat etiprate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Telotristat may reduce everolimus exposure through CYP3A4 induction, risking loss of antitumour efficacy or immunosuppression, which is a concern in neuroendocrine tumour treatment.

How serious is the interaction between Everolimus and Telotristat etiprate?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor tumour response, or everolimus trough levels where used for transplant, and adjust the dose accordingly.

What other medicines interact with Telotristat etiprate?

MediHelp also lists interactions of Telotristat etiprate with, for example, Bupropion, Capecitabine, Flutamide. The full list is on the Telotristat etiprate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in